Evidence map›Paper›PMID 27698361›Full record

ArticleScientific reports2016

Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study.

Mao-Lin Hu, Xiao-Fen Zong, Jun-Jie Zheng, Spiro P Pantazatos, Jeffrey M Miller, Zong-Chang Li, Yan-Hui Liao, Ying He, Jun Zhou, De-En Sang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Mao-Lin HuDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiao-Fen ZongDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jun-Jie ZhengKey Laboratory for NeuroInformation of the Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
Spiro P PantazatosDivision of Molecular Imaging and Neuropathology, New York State Psychiatric Institute and Departments of Psychiatry, Columbia University, New York, NY, USA.
Jeffrey M MillerDivision of Molecular Imaging and Neuropathology, New York State Psychiatric Institute and Departments of Psychiatry and Radiology, Columbia University, New York, NY, USA.
Zong-Chang LiDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yan-Hui LiaoDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Ying HeDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jun ZhouDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
De-En SangDepartment of Radiology, Henan Mental Hospital, the Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Hong-Zeng ZhaoDepartment of Radiology, Henan Mental Hospital, the Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Lu-Xian LvDepartment of Psychiatry, Henan Mental Hospital, the Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Jin-Song TangDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
J John MannDivision of Molecular Imaging and Neuropathology, New York State Psychiatric Institute and Departments of Psychiatry and Radiology, Columbia University, New York, NY, USA.
Xiao-Gang ChenDepartment of Psychiatry, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Central South University · CNColumbia University · USHenan Psychiatric Hospital · CNSecond Xiangya Hospital of Central South University · CNNew York Psychoanalytic Society and Institute · USUniversity of Electronic Science and Technology of China · CNXinxiang Medical University · CN

Funding

Integrative neuroinformatics to relate genomics to neurocircuitry and psychopathologyK01MH108721 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI PANTAZATOS, SPIRO PETER · 2016 to 2019
$739k
NIMH NIH HHS K01 MH108721
6 · The paper itself

Abstract

It is unclear whether abnormal spontaneous neural activation patterns found in chronic schizophrenia patients (CSP) are part of the pathogenesis of disease, consequences of chronic illness, or effects of antipsychotic treatment. We performed a longitudinal resting-state functional magnetic resonance imaging (fMRI) study in 42 treatment-naïve first-episode schizophrenia patients (FESP) at baseline and then after 8-weeks of risperidone monotherapy, and compared the findings to 38 healthy volunteers. Spontaneous brain activity was quantified using the fractional amplitude of low-frequency fluctuations (fALFF) and regional homogeneity (ReHo) and compared between patients and controls. Pretreatment, patients exhibited higher fALFF in left caudate compared with controls. After treatment, patients had elevated fALFF in bilateral putamen and right caudate, and increased ReHo in right caudate and left putamen. Greater increase of fALFF in the left putamen correlated with less improvement in positive symptoms. Thus, abnormalities of spontaneous neural activity in chronic schizophrenia is at least partly due to a medication effect. The observed post-treatment increase in striatal intrinsic activity may reflect counter-therapeutic functional adaptation to dopamine D2 receptor occupancy required for medication effects on psychosis.

Indexed as

AdultAntipsychotic AgentsBrainCase-Control StudiesFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleRisperidoneSchizophreniaYoung AdultAntipsychotic AgentsRisperidone

Identifiers

PMID27698361
PMCPMC5048418
OpenAlexW2529105467

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.